Any feedback?
Literature summary for 3.4.21.36 extracted from
- Crystallization and preliminary diffraction studies of porcine pancreatic elastase in complex with a novel inhibitor (2007), Protein Pept. Lett., 14, 93-95.
Crystallization (Commentary)
| Crystallization (Comment) | Organism |
|---|---|
| in complex with inhibitor N-benzyl-2-oxo-4-(phenylsulfonyl)azetidine-1-carboxamide, sitting drop vapour diffusion method, in 200 mM sodium sulfate and 100 mM sodium acetate at pH 5.1 | Sus scrofa |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| N-benzyl-2-oxo-4-(phenylsulfonyl)azetidine-1-carboxamide | JM54, potent and irreversible inhibitor | Sus scrofa |  |
Molecular Weight [Da]
| Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
|---|---|---|---|
| 25900 | - |
SDS-PAGE | Sus scrofa |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Sus scrofa | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| pancreas | - |
Sus scrofa | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| PPE | - |
Sus scrofa |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
